NEUROMODULATION OF THE ANTIBODY RESPONSE
抗体反应的神经调节
基本信息
- 批准号:6570490
- 负责人:
- 金额:$ 16.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-01 至 2003-08-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte SCID mouse antibody formation beta adrenergic receptor cell adhesion molecules cell line clone cells cytokine gene targeting helper T lymphocyte immunoglobulin isotypes laboratory mouse leukocyte activation /transformation neuroimmunomodulation norepinephrine receptor expression sympathetic nervous system
项目摘要
DESCRIPTION (applicant's abstract): Our long term goal is to understand
the mechanism by which a line of communication is maintained between the
immune system and the sympathetic nervous system, as well as the
mechanism by which disruption of this communication link affects immune
homeostasis. Sympathetic nerve fibers release norepinephrine within
lymphoid organs during an immune response to bind to adrenergic
receptors expressed on immune cells. Findings from this laboratory show
that B cells and clones of CD4+ T-helper (Th)-1 cells express detectable
levels of the beta-2-adrenergic receptor (b2AR) protein and mRNA, while
clones of Th2 cells do not. Our results also show that b2AR stimulation
on the B cell, but not the Th2 cell, increases the frequency of B cells
that differentiate into IgM-, IgG1-, and IgE-secreting cells through a
mechanism that appears to involve a b2AR-induced increase in B7-2
expression on the B cell. In contrast, b2AR stimulation on the Th1 cell
appears to play a more critical role to increase the frequency of B
cells that differentiate into IgG2a-secreting cells. However, in both
the Th1 and Th2 cell-dependent antibody response, enhancement appears
to depend on the activation state of the cells at the time of b2AR
stimulation. These findings have led us to propose the hypothesis that
norepinephrine stimulation of the b2AR on lymphocytes is essential for
the induction of maximal antibody production against a Th cell-dependent
antigen. The specific aims of this research will be 1) To determine if
the presence of the b2AR on lymphocytes is essential for norepinephrine
to enhance the antibody response by using mice in which the b2AR gene
has been disrupted; 2) To determine the mechanism responsible for
antibody enhancement by testing if the increase in B cell activity is
induced directly by b2AR stimulation on the B cell and/or induced
indirectly by the B cell influencing Th cell activity and/or by b2AR
stimulation on the Th1 cell; and 3) To determine the mechanism by which
the antibody enhancement is influenced by the time of b2AR stimulation
in relation to the state of Th cell and B cell activation. For all
experiments, cells from b2AR knockout mice will be used to confirm
findings obtained from cells of normal mice. These studies will provide
not only insight into the mechanisms important to homeostatic regulation
by norepinephrine of the Th cell-dependent antibody response, but also
insight into the rational development of approaches by which changes in
antibody production associated with immune and nervous system diseases
can be prevented and reversed.
描述(申请人摘要):我们的长期目标是了解
一种机制,通过该机制可以在两个
免疫系统和交感神经系统,以及
此通信链路中断影响免疫力的机制
动态平衡。交感神经纤维在体内释放去甲肾上腺素
免疫反应中的淋巴器官与肾上腺素能结合
免疫细胞上的受体表达。这个实验室的发现表明
B细胞和CD4+T辅助细胞(Th)-1细胞克隆表达可检测
β2肾上腺素能受体(B2AR)蛋白和mRNA的水平,而
Th2细胞的克隆则不能。我们的结果还表明,B2AR刺激
在B细胞上,而不是Th2细胞上,增加了B细胞的频率
通过一种细胞因子分化为分泌IgM、IgG1和IgE的细胞
似乎涉及B2AR诱导B7-2增加的机制
B细胞上的表达。相比之下,B2AR对Th1细胞的刺激
似乎在增加B的频率方面起到了更关键的作用
分化为IgG2a分泌细胞的细胞。然而,在这两种情况下
Th1和Th2细胞依赖性抗体反应增强
取决于B2AR时细胞的激活状态
刺激。这些发现使我们提出了这样的假设
去甲肾上腺素对淋巴细胞B2AR的刺激是
诱导针对Th细胞依赖的最大抗体产生
抗原。这项研究的具体目标将是:1)确定
淋巴细胞上B2AR的存在是去甲肾上腺素所必需的
利用携带B2AR基因的小鼠增强抗体应答
已经中断;2)确定导致
通过检测B细胞活性的增加是否
由B2AR刺激B细胞直接诱导和/或诱导
间接通过B细胞影响Th细胞活性和/或通过B2AR
刺激Th1细胞;3)确定其作用机制。
抗体增强受B2AR刺激时间的影响
与Th细胞和B细胞的活化状态有关。为所有人
实验中,B2AR基因敲除小鼠的细胞将被用来证实
从正常小鼠的细胞中获得的发现。这些研究将提供
不仅洞察对动态平衡调节很重要的机制
由去甲肾上腺素引起的Th细胞依赖性抗体反应,也
洞察理性发展的方法,通过这些方法改变
与免疫和神经系统疾病相关的抗体产生
是可以预防和逆转的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA M SANDERS其他文献
VIRGINIA M SANDERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA M SANDERS', 18)}}的其他基金
Ohio State University DISCOVERY PREP for Biomedical Research
俄亥俄州立大学生物医学研究发现准备
- 批准号:
8230591 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Ohio State University DISCOVERY PREP for Biomedical Research
俄亥俄州立大学生物医学研究发现准备
- 批准号:
8449635 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Ohio State University DISCOVERY PREP for Biomedical Research
俄亥俄州立大学生物医学研究发现准备
- 批准号:
7761119 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
Ohio State University DISCOVERY PREP for Biomedical Research
俄亥俄州立大学生物医学研究发现准备
- 批准号:
8036978 - 财政年份:2010
- 资助金额:
$ 16.22万 - 项目类别:
相似海外基金
Analysis of transmembrane proteins activity in urological cancers using humanized SCID mouse
使用人源化 SCID 小鼠分析泌尿系统癌症中的跨膜蛋白活性
- 批准号:
19K09674 - 财政年份:2019
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Core B - SCID Mouse : Human Xenograft Core (Jordan Pober, MD/PhDP.I.)
核心 B - SCID 小鼠:人类异种移植核心(Jordan Pober,医学博士/博士)
- 批准号:
6756347 - 财政年份:2004
- 资助金额:
$ 16.22万 - 项目类别:
EXPERIMENTAL ANALYSIS OF VASCULER CHANGES IN CHRONIC ALLOGRAFT REJECTION USING HUMANIZED SCID MOUSE MODEL.
使用人源化 SCID 小鼠模型对慢性同种异体移植排斥中的血管变化进行实验分析。
- 批准号:
14571526 - 财政年份:2002
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The heat shock protein(HSP) was investigated as the pathogenesis of focal infection with tonsil by the SCID mouse model
通过SCID小鼠模型研究热休克蛋白(HSP)作为扁桃体局灶性感染的发病机制
- 批准号:
14571629 - 财政年份:2002
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
通过原位植入手术切除的肺癌组织的原代培养细胞建立类患者 SCID 小鼠模型。
- 批准号:
14571269 - 财政年份:2002
- 资助金额:
$ 16.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)